Downregulation of p57 accelerates the growth and invasion of hepatocellular carcinoma

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Downregulation of p57kip2 promotes cell invasion via LIMK/cofilin pathway in human nasopharyngeal carcinoma cells

(2011) Shu-Er Chow et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

p57 Kip2 is a downstream effector of BCR–ABL kinase inhibitors in chronic myelogenous leukemia cells

(2010) Adriana Borriello et al.   CARCINOGENESIS

PTEN regulates angiogenesis and VEGF expression through phosphatase-dependent and -independent mechanisms in HepG2 cells

(2010) Tao Tian et al.   CARCINOGENESIS

RhoGTPases and Rho-effectors in hepatocellular carcinoma metastasis: ROCK N' Rho move it

(2010) Carmen Chak-Lui Wong et al.   LIVER INTERNATIONAL

p57Kip2 is a repressor of Mash1 activity and neuronal differentiation in neural stem cells

(2009) B Joseph et al.   CELL DEATH AND DIFFERENTIATION

p57KIP2: "Kip"ing the Cell under Control

(2009) I. S. Pateras et al.   MOLECULAR CANCER RESEARCH

The Cdk inhibitor p57Kip2 controls LIM-kinase 1 activity and regulates actin cytoskeleton dynamics

(2009) P Vlachos et al.   ONCOGENE

RSK1 drives p27Kip1 phosphorylation at T198 to promote RhoA inhibition and increase cell motility

(2009) M. D. Larrea et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

CDKN1C/p57kip2is a candidate tumor suppressor gene in human breast cancer

(2008) Pamela S Larson et al.   BMC CANCER

Down-regulation of p57Kip2 Induces Prostate Cancer in the Mouse

(2008) R. J. Jin et al.   CANCER RESEARCH

CDK Inhibitors: Cell Cycle Regulators and Beyond

(2008) Arnaud Besson et al.   DEVELOPMENTAL CELL

Vitamin D3 analogue EB1089 inhibits the proliferation of human laryngeal squamous carcinoma cells via p57

(2008) L. Lu et al.   MOLECULAR CANCER THERAPEUTICS

MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma

(2008) F Fornari et al.   ONCOGENE